Editorial Policy

Pepcite publishes cited compound references, regulatory records, and research-backed guides. This policy explains how that content is sourced, written, reviewed, and maintained, so you can judge the information for yourself and decide how much weight to give it.

Our mission

Our aim is to make peptide information accurate, clearly sourced, and genuinely useful. Most of what circulates online comes from forums, social media, clinic marketing, or vendor product pages — usually without citations, without any note on how strong the evidence is, and without clear disclaimers. We exist to raise that standard.

We are an educational publisher, not a healthcare provider, a pharmacy, or a peptide vendor. We do not diagnose, treat, prescribe, or sell. Our content is built to help researchers and informed readers understand what the published evidence and the regulatory record actually say — and where they are limited.

How content is sourced

Substantive claims — mechanisms, pharmacokinetics, reported effects, regulatory status, and any dose figures reported from studies — are drawn from one or more of the following:

Primary sources (highest priority)

  • Peer-reviewed journal articles in indexed biomedical journals — randomized controlled trials, clinical pharmacology studies, systematic reviews, and meta-analyses.
  • FDA prescribing information and labeling for approved products, which represent the most rigorously reviewed data available.
  • Clinical trial registrations and results from ClinicalTrials.gov and equivalent registries, especially for compounds in active development.

Secondary sources (supplementary)

  • Professional society guidelines and consensus statements.
  • Government and regulatory publications — FDA safety communications, DEA scheduling decisions, Federal Register determinations.
  • Established medical reference texts and pharmacology databases.

What we do not treat as sources

  • Forum posts, social media, and anecdotal user reports without corroborating published evidence.
  • Vendor or manufacturer marketing (aside from factual product specifications).
  • AI-generated text that has not been verified against the primary literature.
  • Other peptide sites, unless they cite primary sources we can independently confirm.

Content creation process

Every entry — a compound reference, a regulatory record, a guide, or a blog article — follows the same steps:

1. Research and literature review

Before anything is written, we search the literature (PubMed, Google Scholar, FDA label databases such as DailyMed and Drugs@FDA) and the relevant regulatory sources, prioritizing human clinical data over preclinical data where both exist.

2. Drafting with inline citations

Content is drafted with citations placed at the point of each factual claim. We don’t write first and add sources later — the evidence drives the content.

3. Accuracy verification

Before publishing, key claims are cross-checked against the cited source, regulatory status is confirmed against current FDA and DEA records, and any figures are re-checked. Dosing is compiled from FDA labeling, clinical trials, and established protocols and presented with its sources — as reference information, not individualized medical advice.

4. Publication and monitoring

Nothing is treated as final. Entries are revisited as new trial results arrive, labeling changes, or errors are found.

Authorship and review

Reference and regulatory pages carry the Pepcite Editorial Team byline; we do not present the team name as a fictional individual. Where a page has been reviewed by a separate qualified professional, that reviewer and the review date are identified. When no reviewer is listed, the page has not been represented as independently reviewed.

Researchers named in a page’s sources authored or co-authored the cited publications. Listing them does not mean they wrote, reviewed, sponsored, or endorsed our content.

Citation standards

  • Inline, not buried: citations sit where the claim is made, so you can see which source supports which statement.
  • Linked to the original: wherever possible, a citation links to the full text or abstract so you can verify it yourself.
  • Numbered and consistent: sources are numbered within each entry; one source may be cited more than once.
  • Source diversity: we aim to cite multiple independent sources for important claims, and note it plainly when only one exists.

Evidence quality and limitations

Not all evidence is equal, and readers deserve to know the difference. We label claims by the strength of what supports them:

Strong

Multiple randomized trials, meta-analyses, or approved labeling. Presented with confidence.

Moderate

Limited trials, observational data, or expert-consensus guidelines. Framed as “research suggests,” not established fact.

Preliminary

Animal studies, in vitro work, or very early human trials. Explicitly flagged, with the gap to proven human outcomes noted.

Insufficient

Claims that circulate widely but lack credible published support. We say so directly rather than repeat them.

Updates and corrections

Routine updates

We review published content periodically, prioritizing compounds in active development (where new data can change the picture), high-traffic pages, and pages readers have flagged.

Corrections

When we find an error — a wrong citation, a misstated finding, an outdated regulatory status, or any other inaccuracy — we fix it promptly. For substantive corrections we note the change and its date at the top of the page.

Reader-reported issues

If you spot an error, a broken citation, or a misleading statement, tell us through the Contact page with the page URL and a description. We investigate every report.

Source links

We link out to published studies, FDA and regulatory documents, and other authoritative references so you can verify our claims. These links are for verification and do not imply endorsement.

Vendor and product links

Where a link to a third-party research-use-only supplier appears, the vendor is named and the link points to a specific page. Such links exist because readers ask where materials can be sourced for research; their presence is not an endorsement of a vendor’s quality or purity claims. We do not accept payment to write favorable content, alter what we report, or suppress safety information. Any affiliated or compensated links are disclosed as such.

Editorial independence

  • No outside editorial control. No vendor, manufacturer, or advertiser has input into, review authority over, or approval rights for our content. We decide what to cover, what to cite, and what cautions to include based on our own judgment and the available literature.
  • No pay-for-placement. We do not accept payment to create content about a specific compound, feature a product, or remove unfavorable information.
  • Nothing suppressed. If the published evidence shows a compound carries specific risks or limited support, we include that regardless of whether it conflicts with popular claims or commercial interests.
  • Disclosure of affiliations. Where Pepcite has a commercial relationship relevant to something we publish, we disclose it so you can weigh it.

What this site is not

  • Not a medical provider. Nothing here is medical advice, diagnosis, or treatment, and there is no provider-patient relationship.
  • Not a pharmacy. We do not sell, distribute, compound, or dispense any peptides or controlled substances.
  • Not a clinical research organization. We do not run trials, sponsor research, or collect patient data.
  • Not a substitute for professional guidance. Anyone considering peptides in a clinical context should consult a qualified professional who can weigh their individual circumstances.

Contact

Questions about this policy, corrections, or content concerns can be sent through the Contact page. We prioritize reports of potential errors and safety-related concerns.

This editorial policy was last updated in July 2026.